← Leaderboards
Pradyumma D Phatak
University Of Rochester
$1,003,628
Attributed
$2,707,200
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $738.1K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,707,200 · 3
By mechanism
R24$2,044,286 · 1
R01$660,914 · 1
R13$2,000 · 1
Top collaborators
- Paul Clifford Adams3 shared
- James C Barton3 shared
- Christine E Mclaren3 shared
- Gordon D Mclaren3 shared
- Nathan Subramaniam3 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Arthur J. Moss$13,356,209
- James Palis$20,960,389
- Michael Rusty Elliott$4,421,866
- Chawnshang Chang$14,165,223
- David H Mathews$9,788,719
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAlcohol ConsumptionAllelesArchitectureClinical PracticeClinical ResearchCodeComparison GroupControl GroupsCysteineDesignDiagnosisDietary IronDna Sequence AnalysisEpidemiologyEquilibriumEuropeanExome SequencingExonsFamily MemberFerritinFirst Degree RelativeFollow-UpAbsorption
Grant awards (7)
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes$738,146
R24 · FY2016 · DK
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes$710,891
R24 · FY2015 · DK
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes$595,249
R24 · FY2014 · DK
Achieving Iron Balance in Men & Women with Hemochromatosis$2,000
R13 · FY2006 · HL · contact PI
HEMOCHROMATOSIS--GENETIC PREVALENCE AND PENETRANCE$75,000
R01 · FY2002 · HL
HEMOCHROMATOSIS--GENETIC PREVALENCE AND PENETRANCE$332,206
R01 · FY2001 · HL
HEMOCHROMATOSIS--GENETIC PREVALENCE AND PENETRANCE$253,708
R01 · FY2000 · HL